SastaSundar Healthbuddy, Mitsubishi Corp sign deal worth Rs 100 crore for affordable healthcare

Published On 2019-08-27 04:15 GMT   |   Update On 2021-08-14 06:22 GMT

Founder and CEO Ravi Kant Sharma added: "The partnership with Mitsubishi Corporation will help us to connect global resources with local care. It is a milestone in our journey to expand our operations in India."


Kolkata: Mitsubishi Corporation of Japan has signed an agreement to invest Rs 100 crore in SastaSundar Healthbuddy, a digital healthcare platform with a mission to provide consistent access to affordable healthcare in a convenient manner.


SastaSundar is supported by a network of independent pharmacies called Healthbuddies and has an integrated model of online plus offline plus logistic plus data.


SastaSundar has also innovated personal health tech solutions to provide personalized services using technology, according to a statement issued on Monday.


Mitsubishi's investment follows recent investments of Rs 70.49 crore by Rohto Pharmaceuticals of Japan in SastaSundar Ventures Ltd.


"The global experience of Mitsubishi Corporation will help us to scale our business," said SastaSundar's Founder and Executive Chairman B L Mittal.


Read Also: CK Birla Hospital for Women to invest up to Rs 1,000 cr, add 14 hospitals by end of 2025


"Between us, there is a match of the mission of the social objective behind the business. This is a solid partnership for the future and for making the lives of millions healthy and happy," he said.


Founder and CEO Ravi Kant Sharma added: "The partnership with Mitsubishi Corporation will help us to connect global resources with local care. It is a milestone in our journey to expand our operations in India."


Read Also: Strides Pharma found destroying, dumping drug production documents: USFDA Investigation

Tags:    
Article Source : ANI

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News